Lexicon Pharmaceuticals LXRX License — Variable consideration, sales milestones

Similar metrics at other companies

MLTXLicense — Variable consideration amount

$8.1M0.0%

CRNXLicense — Milestone revenue

$1.5M—

SUPNLicense — Revenue, remaining performance obligation, variable consideration amount

$470M—

MLTXLicense — Revenue remaining performance obligation additional variable consideration amount

$344.3M+6.2%

EXELLicense revenues — Revenue from contract with customer, commercial sales milestone

$5.3M+393%

SUPNLicense — Revenue recognized

$20M+433%

Other financials

Income statement

See full

Revenue$21.1M+1,572%

Gross profit$21.0M+1,604%

Operating income-$996.0K+96.1%

Net income-$1.0M+95.9%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$67.1M+6.7%

Total debt$57.7M-45.7%

Total equity$202.9M+64.9%

Total assets$268.8M-9.7%

Cash flow

See full

Operating cash flow-$14.7M+66.4%

CapEx--100%

Free cash flow-$17.2M+21.5%

Valuation

See full

Market cap$986.12M+273%

Enterprise value$976.73M+219%

P/S14.2×+5.7×

Profitability

See full

Gross margin99.5%+1.5pp

Operating margin-34.8%-16.8pp

Net margin-37.5%-18.1pp

FCF margin-578.5%-283pp

Returns & leverage

See full

Return on equity-16%-7.2pp

Debt / equity0.3×-0.6×

Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept lxrx:RevenueVariableConsiderationSalesMilestones.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's license — variable consideration, sales milestones.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lexicon Pharmaceuticals's license — variable consideration, sales milestones?: Lexicon Pharmaceuticals (LXRX) reported license — variable consideration, sales milestones of $475M in Q1 2026.
What does license — variable consideration, sales milestones mean?: This metric tracks revenue triggered by the attainment of pre-defined commercial sales thresholds for licensed products. It serves as a performance indicator for the market success of products managed by partners. Consistent achievement of these milestones demonstrates strong commercial demand and effective product positioning.